Clinical Trial Update: A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes termination of a safety study evaluating niraparib and dostarlimab in combination with radiation therapy for rectal cancer (Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Dostarlimab (Jemperli) (dostarlimab)
• Niraparib (Zejula) (Niraparib)

Snippet

Sponsor: University of Iowa | Conditions: Rectal Neoplasms, Rectal Neoplasm Malignant | Phase 1, Phase 2 | Status: TERMINATED